Losartan Recall Expanded by FDA Over Cancer Concerns

FDA Alerts
Losartan

Losartan Lawsuit The FDA reported that they have found traces of unexpected impurities in certain batches of Losartan.  The impurity that has been detected is N-Methylnitrosobutyric acid or NMBA.  The company is only recalling batches of Losartan that contain more than the acceptable daily intake levels of NMBA set by the FDA. Losartan is an…

Read More

Drug Recall Criteria According to the FDA

FDA Alerts
Drug Recall from FDA

When drug products are removed from shelves and taken off the market by the manufacturers, it is done so in accordance with a drug recall – either voluntarily or involuntarily. When a recall is initiated by the manufacturer, it is a voluntary recall; the U.S. FDA can also request a recall. Recalls can be initiated…

Read More